Strikingly, PIK3CA aberrations were associated with sensitivity to the MEK inhibitor when it occurred in colon cancer lines, and resistance when they occurred in breast cancer lines; there were no associations noted in the context of other lineages. The gene discussed is MAP2K7; the disease is breast cancer.